Vitrectomy for endophthalmitis: 5-year study of outcomes and complications
Guy Simon Negretti, WengOnn Chan, Carlos Pavesio, Mahiul Muhammed Khan Muqit, Guy Simon Negretti, WengOnn Chan, Carlos Pavesio, Mahiul Muhammed Khan Muqit
Abstract
Background/aims: To analyse the complications and outcomes of vitrectomy surgery for endophthalmitis.
Methods: This was a retrospective case series. All cases that underwent 23-gauge vitrectomy surgery for endophthalmitis at a tertiary centre between 1 February 2013 and 1 February 2018 were included. Main outcome measures were as follows: visual acuity (VA) at final visit and post-vitrectomy complications.
Results: 33 patients were included in the study with 20 men and 13 women, average age 63 years. Main post-surgical causes for endophthalmitis included phacoemulsification (n=9), trabeculectomy (n=5), intravitreal injection (n=5), corneal graft (n=4), vitreoretinal surgery (n=3) and endogenous endophthalmitis (n=6). Average follow-up was 18 months (SD 14). 21/33 (64%) patients had baseline perception of light VA. Analysis of exogenous endophthalmitis cases only demonstrated: mean LogMAR VA improved significantly from 2.68 to 1.66 (p=0.001). At final follow-up, 12% had VA of 6/12 or better, and 28% had VA of 6/36 or better. Vitrectomy within 7 days resulted in improved final VA outcomes (1.49 vs 2.16 LogMAR, p=0.032). Complications included retinal detachment (24.2%), macular hole (3%), hypotony (6%), suprachoroidal haemorrhage (3%) and enucleation/evisceration (6%).
Conclusion: Vitrectomy for endophthalmitis leads to VA gains in some cases. Surgical outcomes may be improved with early vitrectomy performed within 7 days of the initial event for exogenous endophthalmitis. Patients should be advised of the potential risk of severe complications with/and without surgery.
Keywords: infection; inflammation; retina; treatment surgery.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
References
- Endophthalmitis Vitrectomy Study Group Results of the endophthalmitis vitrectomy study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. endophthalmitis vitrectomy Study Group. Arch Ophthalmol 1995;113:1479–96.
- Kuhn F, Gini G. Ten years after are findings of the endophthalmitis vitrectomy study still relevant today? Graefes Arch Clin Exp Ophthalmol 2005;243:1197–9. 10.1007/s00417-005-0082-8
- Tan CSH, Wong H-K, Yang FP, et al. . Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis. Eye 2008;22:150–1. 10.1038/sj.eye.6702987
- Almanjoumi AM, Combey A, Romanet JP, et al. . 23-Gauge transconjunctival sutureless vitrectomy in treatment of post-operative endophthalmitis. Graefes Arch Clin Exp Ophthalmol 2012;250:1367–71. 10.1007/s00417-012-1926-7
- Chiquet C, Aptel F, Combey-de Lambert A, et al. . Occurrence and risk factors for retinal detachment after pars plana vitrectomy in acute postcataract bacterial endophthalmitis. Br J Ophthalmol 2016;100:1388–92. 10.1136/bjophthalmol-2015-307359
- Brillat-Zaratzian E, Bron A, Aptel F, et al. . Friends group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis. Graefes Arch Clin Exp Ophthalmol 2014;252:101–7. 10.1007/s00417-013-2503-4
- Moorfields Eye Hospital Annual report and accounts 2016/17. Available: [Accessed 26 Feb 2019].
- Moorfields Eye Hospital Infection control annual report 2017, 2017. Available: [Accessed 26 Feb 2019].
- Behera UC, Budhwani M, Das T, et al. . Role of early vitrectomy in the treatment of fungal endophthalmitis. Retina 2018;38:1385–92. 10.1097/IAE.0000000000001727
- Ho I-V, Fernandez-Sanz G, Levasseur S, et al. . Early pars plana vitrectomy for treatment of acute infective endophthalmitis. Asia Pac J Ophthalmol 2019;8:3–7. 10.22608/APO.2018414
- Rayess N, Rahimy E, Shah CP, et al. . Incidence and clinical features of post-injection endophthalmitis according to diagnosis. Br J Ophthalmol 2016;100:1058–61. 10.1136/bjophthalmol-2015-307707
- Tarragó R, Olea JL, Ramírez C, et al. . Endophthalmitis after intravitreal injections. incidence, management and prognosis. Arch Soc Esp Oftalmol 2017;92:107–11. 10.1016/j.oftale.2016.09.019
- Busbee BG, Recchia FM, Kaiser R, et al. . Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology 2004;111:1495–503. 10.1016/j.ophtha.2004.01.028
Source: PubMed